会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • SYSTEM FOR DELIVERING NEBULIZED CYCLOSPORINE AND METHODS OF TREATMENT
    • 输送神经性环磷酰胺的系统和治疗方法
    • WO2007100741A3
    • 2007-12-27
    • PCT/US2007004861
    • 2007-02-22
    • NOVARTIS PHARMA AGLAI JOHNNY
    • LAI JOHNNY
    • A61M16/10
    • A61M16/105A61M16/0093A61M16/1065
    • Systems comprising a pressurized delivery device and a formulation of cyclosporine coupled to an exhalation filter or trap that is capable of preventing cyclosporine from escaping into the local environment are provided. An apparatus for use in the system comprises either an exhalation filter and a pressurized delivery device, wherein the exhalation filter is capable of providing high filter efficiency and maintaining low filter resistance after usage with the formulation, or a trap which provides a means for expired gas to be released into a solvent chamber containing a solvent with a high affinity for cyclosporine. These systems may be used to treat patients with pulmonary disorders, organ transplant patients such as lung transplant patients, and other immune-related disorders.
    • 提供了包括加压输送装置和联接到呼气过滤器或捕集器的环孢菌素制剂的系统,其能够防止环孢菌素逃逸到局部环境中。 用于该系统的装置包括呼气过滤器和加压输送装置,其中呼气过滤器能够在与配方一起使用之后提供高过滤效率并保持低过滤器阻力,或者提供用于呼出气体的装置的捕集器 被释放到含有对环孢菌素具有高亲和力的溶剂的溶剂室中。 这些系统可用于治疗肺部疾病患者,器官移植患者如肺移植患者,以及其他免疫相关疾病。
    • 4. 发明申请
    • SYSTEM FOR DELIVERING NEBULIZED CYCLOSPORINE AND METHODS OF TREATMENT
    • 递送环磷酰胺系统和治疗方法
    • WO2007100741A2
    • 2007-09-07
    • PCT/US2007/004861
    • 2007-02-22
    • NOVARTIS PHARMA AGLAI, Johnny
    • LAI, Johnny
    • A61M16/10
    • A61M16/105A61M16/0093A61M16/1065
    • Systems comprising a pressurized delivery device and a formulation of cyclosporine coupled to an exhalation filter or trap that is capable of preventing cyclosporine from escaping into the local environment are provided. An apparatus for use in the system comprises either an exhalation filter and a pressurized delivery device, wherein the exhalation filter is capable of providing high filter efficiency and maintaining low filter resistance after usage with the formulation, or a trap which provides a means for expired gas to be released into a solvent chamber containing a solvent with a high affinity for cyclosporine. These systems may be used to treat patients with pulmonary disorders, organ transplant patients such as lung transplant patients, and other immune-related disorders.
    • 提供了包括加压输送装置和联合到呼出过滤器或捕集器的环孢菌素制剂的系统,其能够防止环孢菌素逃逸到局部环境中。 用于该系统的装置包括呼气过滤器和加压输送装置,其中呼气过滤器能够在配制剂使用后提供高过滤效率和维持低过滤阻力,或提供呼出气体的装置 被释放到含有对环孢菌素具有高亲和力的溶剂的溶剂室中。 这些系统可用于治疗肺部疾病患者,器官移植患者如肺移植患者和其他免疫相关疾病。
    • 5. 发明申请
    • EMULSIONS FOR AEROSOLIZATION AND DRUG DELIVERY
    • 用于气雾剂和药物递送的乳剂
    • WO9924016A8
    • 1999-07-29
    • PCT/US9823900
    • 1998-11-09
    • SONUS PHARMA INCLAI JOHNNYKESSLER DEAN RQUAY STEVEN C
    • LAI JOHNNYKESSLER DEAN RQUAY STEVEN C
    • A61K9/00A61K9/107A61K9/12
    • A61K9/0026A61K9/0078
    • Compositions containing drug- or therapeutic agent-containing solutions and fluorocarbons are disclosed for pulmonary delivery of the drug or therapeutic agent. Suitable fluorocarbons have relatively high vapor pressures or corresponding low boiling points, preferably between about -30 DEG to about 150 DEG C, and include dodecafluoropentane, dodecafluoroneopentane, perfluorocyclopentane, perfluoro-2-methyl pentane, perfluorohexane, perfluoroheptane, perfluorooctane, perfluorodecalin and isomers and mixtures thereof. Aerosolized emulsions of these fluorocarbons produce fine aerosol particles of
    • 含有含药物或治疗剂的溶液和碳氟化合物的组合物被公开用于药物或治疗剂的肺部递送。 合适的碳氟化合物具有较高的蒸气压或相应的低沸点,优选约-30至约150℃,包括十二氟戊烷,十二氟戊酮戊烷,全氟环戊烷,全氟-2-甲基戊烷,全氟己烷,全氟庚烷,全氟辛烷,全氟萘烷和异构体和 其混合物。 这些碳氟化合物的雾化乳剂产生≤5微米的精细气溶胶颗粒,并且还可以提供药物或治疗剂的改善的溶解度。 碳氟化合物也具有足够高的蒸气压,并且以足够小的量使用,以有效地将药物或治疗剂递送至肺,然后通过蒸发离开肺的空气空间。